MC-60454AB ORANGE R7061 MC-60946PE ORANGE MC-60958PE ORANGE 021C

NYSE: AVNT) AVIENT CORPORATION I N V E S T O R M E E T I N G S M A Y 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 43 Capex / Revenue 2022E (%) AV I E N T I S A S S E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 4 3 3 5 5 7 7 8 11 A vi en t A vi en t P F F U L K W R P P G R P M A V Y F M C H U N H X L E C L E M N C E A S H S C L Source: Peer data per Bloomberg market data as of April 21, 2022. Source: Peer data per Bloomberg market data as of April 21, 2022 86 82 86 86 84 78 77 89 86 81 80 76 76 76 67 67 11 (12) A vi en t A vi en t P F F U L K W R P P G R P M A V Y F M C U N V R B N R H U N H X L E C L C E A S H E M N S C L A LB 12% 18% 16% 15% 15% 14% 14% 28% 28% 26% 25% 22% 21% 19% 16% 12% 9% 9% A vi en t T od ay A vi en t P F A V Y P P G K W R FU L R P M C E A LB FM C A S H E C L E M N H X L H U N S C L B N R U N V R Median: 21%Median: 15% 2 0 2 2 E B I T DA M A RG I N S V S .

Microsoft PowerPoint - Avient March IR - Fermium AVIENT CORPORATION (NYSE: AVNT) M A R C H 1 8 , 2 0 2 1 I R M E E T I N G S H O S T E D B Y F E R M I U M R E S E A R C H D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. F U T U R E G ROW TH I N E XC E S S O F G D P I S D R I V E N B Y: Our company is positioned to sustainably grow at a rate that exceeds GDP. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 26 Avient reflects 2021 estimated EBITDA of $510M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 11.3 18.6 14.3 13.6 13.3 12.2 10.7 28.8 26.3 23.3 14.6 12.4 11.7 11.6 11.2 11.0 10.6 10.3 9.6 9.1 8.5 7.2 A vi e n t K W R A V Y R P M P P G G C P F U L H X L A L B E C L IF F F M C A S H F O E B N R C E G R A E M N S C L U N V R K R A H U N Median: 11.2xMedian: 13.5x S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Microsoft PowerPoint - AVNT Q4 2022 Earnings Presentation AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 2 R E S U L T S A N D 2 0 2 3 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 1 5 , 2 0 2 3 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. EPS (1) $0.14 $2.67 $3.04 2006 2018 2022PF TO P- TI E R S U S TA I N A B I L I T Y P E R F O R M A NC E A N D R E C O G N I T I O N Industry Sustainability Standards 90th percentile 84th ESG Ratings Performance 3 1 4 10 PEOPL E C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $17 million raised since 2010 Diversity & Inclusion 11 2 0 2 2 R E S U L T S Q4 EBITDA BRIDGE ( P R O F O R M A T O TA L C O M PA N Y ) 13 $ millions CAI: Price / Mix 42 Inflation (20) SEM: Price / Mix 14 Inflation (10) Net Price Benefit 26 Wage and Energy Inflation (13) Clariant Color Integration Synergies 4 Incentives, Other Employee Costs 21 FX (10) Q4 2022 $107 Adjusted EBITDA Q4 2021 $ 132 Demand (50) Russia Import Sales (3) • Demand contraction especially prevalent in EMEA and Asia • Pricing continues to cover inflation of raw materials, wages and energy P ROV E N T R AC K R E C O R D O F S T RO N G A N D I M P ROV I N G F R E E C A S H F LOW G E N E R AT I O N 14 • Periods of economic weakness have driven higher levels of cash generation due to working capital management • Anticipate continued strong free cash flow generation and conversion despite global uncertainty 78% 78% 80% 80% 81% 78% 84% 83% 80% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 50 100 150 200 250 300 350 400 F re e C a s h F lo w C o n v e rs io n F re e C a s h F lo w FCF $ AVNT FCF Conversion % S&P FCF Conversion % Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. 2020 is pro forma for Clariant Color and 2022 is pro forma for Avient Protective Materials Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 28 79 87 81 79 76 73 90 77 76 75 73 64 59 33 A vi e n t K W R P P G F U L A V Y R P M F M C C E A S H H X L E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.

Odmítnutí obchodovat – dohoda s konkurentem o bojkotu nebo neobchodování s třetí stranou. 2. Kontakty s konkurenty. × Dohodnout se s kýmkoli na neobchodování s další stranou, nabádat k tomu nebo to nařizovat

S U S TA I NA B I L I T Y • Most recent Sustainability report substantially expanded disclosure on key environmental and social topics Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2 0 3 0 S U STA I NA B I L I T Y TA RG E TS 11 F U T U R E G ROW TH I N E XC E S S O F G D P I S D R I V E N B Y: Our company is positioned to sustainably grow at a rate that exceeds GDP. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 A vi e n t K W R A V Y P P G R P M F U L G C P H X L A L B E C L IF F F M C B N R A S H G R A E M N F O E S C L U N V R C E K R A H U N Median: 11.7xMedian: 15.4x S U M M A RY: W H Y I N V E S T I N AV I E N T ?

S U S TA I NA B I L I T Y • Most recent Sustainability report substantially expanded disclosure on key environmental and social topics Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2 0 3 0 S U STA I NA B I L I T Y TA RG E TS 11 F U T U R E G ROW TH I N E XC E S S O F G D P I S D R I V E N B Y: Our company is positioned to sustainably grow at a rate that exceeds GDP. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi e n t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Avient’s Vice President of EH&S and SVP of Global Operations and Process Improvement are responsible for reporting to the EH&S Committee of the Board of Directors. We also track physical security incidents and manage those through the EH&S MS. Avient’s Vice President of EH&S and SVP of Global Operations and Process Improvement are responsible for reporting to the EH&S Committee of the Board of Directors.

Microsoft PowerPoint - AVNT Mar 2022 Presentation AVIENT CORPORATION I N V E S T O R M E E T I N G S (NYSE: AVNT) M A R C H 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Duševní vlastnictví Kupující přebírá veškerá rizika spojená s porušením práv duševního vlastnictví třetích stran z důvodu jakéhokoli využití výrobku Kupujícím v kombinaci s jinými látkami nebo při provozu jakéhokoli výrobního procesu, jakož i veškerých porušení vyplývající z jednání Prodávajícího v souladu s návrhy, specifikacemi nebo pokyny Kupujícího, a Kupující se zavazuje Prodávajícího chránit před těmito riziky a v případě porušení ho odškodnit. S výjimkou případu vyšší moci, pokud není Kupující spokojen s určením Prodávajícího, má jako jediný prostředek nápravy právo ukončit kupní smlouvu bez dalších závazků na základě: (i) písemné výpovědi s výpovědní dobou deseti (10) kalendářních dnů počínaje dnem následujícím po dni doručení výpovědi Prodávajícímu; a (ii) zaplacení všech dosud obdržených Výrobků. 14. Ochrana údajů Kupující tímto souhlasí, že veškeré údaje související s obchodním vztahem mezi Kupujícím a Prodávajícím mohou být Prodávajícím zpracovávány v souladu s příslušnými právními předpisy. 20.